Last reviewed · How we verify

NCT05625672

EFFICIENCY OF HEMOVIGILANCE MODULE TRAININGS GIVEN TO NURSES

Completed NA Last updated 23 November 2022
What this trial tests

NA trial testing Training in Nurse's Role in 125 participants. Completed in 8 July 2022.

Timeline
25 April 2022
Primary endpoint
26 May 2022
8 July 2022

Quick facts

Lead sponsorAnkara Yildirim Beyazıt University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment125
Start date25 April 2022
Primary completion26 May 2022
Estimated completion8 July 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ankara Yildirim Beyazıt University

Who can join

Adults 18 to 64, any sex, with Nurse's Role or Training Group, Sensitivity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the present study is to determine the effectiveness of hemovigilance module training given to nurses.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Training

Trials testing the same drug.

Other recruiting trials for Nurse's Role

Currently open trials in the same condition.

Other Ankara Yildirim Beyazıt University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05625672.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing